ModuleDraft

Internist module: CKD + stroke secondary prevention (BP, antithrombotics, dosing safety) — care coordination

Internist-focused considerations for stroke survivors with CKD: higher vascular risk, medication safety/bleeding risk considerations, BP measurement pitfalls, lab monitoring loops, and when to coordinate with nephrology.

ClinicianClinicianAdvanced25 minClinical (pro)

Educational only

Educational only — dosing/therapy decisions require guideline-concordant individualized assessment and coordination.

Get help now

For major bleeding, severe hyperkalemia symptoms, or acute neuro deficits, seek emergency evaluation.

Key takeaways

  • Recognize CKD as a high-risk modifier in secondary prevention
  • Create a monitoring loop for renal function and medication safety (concept)
  • Identify when to coordinate with nephrology/cardiology for complex antithrombotic and BP management

Risk lens

  • Higher vascular risk
  • Higher bleeding risk

Workflow

  • eGFR trend
  • Electrolytes
  • Anemia
  • Medication reconciliation

Coordination triggers

  • Rapid eGFR decline
  • Recurrent bleeding
  • Complex dual therapy

Practice check

What you’ll practice

These questions are untimed. After you answer all of them, you’ll see your score and a clear next lesson or reference step.

0 of 2 answered

Question 1

1. CKD increases both vascular risk and medication safety complexity after stroke.

Question 2

2. A practical internist task is to…

References

  1. Tier 1
    AHA/ASA 2021 Secondary Prevention Guideline (risk factor management; CKD considerations across comorbidities)
  2. Tier 1
    KDIGO 2024 CKD Guideline (general CKD management)